MedPath

Transversus Abdominis Plane Block Compared to Local Anesthetic Wound Infiltration in Gynecologic Oncology Surgery

Phase 4
Recruiting
Conditions
Analgesia
Surgery
Interventions
Drug: TAP Anesthesia
Drug: Surgeon-Initiated Local Anesthetic
Registration Number
NCT06213454
Lead Sponsor
University of Wisconsin, Madison
Brief Summary

This study is being done to see if preoperative transversus abdominis plane (TAP) analgesia will provide similar postoperative pain control, hospital length of stay, and postoperative outcomes compared to surgeon-initiated wound infiltration with local anesthetic in participants undergoing laparotomy for gynecologic indications.

Detailed Description

Primary Objective

* To evaluate the effects of preoperative TAP analgesia compared to surgeon-initiated wound infiltration with local anesthetic on pain control in subjects undergoing laparotomy.

Secondary Objectives

* To evaluate the effects of preoperative TAP analgesia compared to surgeon-initiated wound infiltration with local anesthetic on subject-rated perception of pain in subjects undergoing laparotomy.

* To evaluate the effects of preoperative TAP analgesia compared to surgeon-initiated wound infiltration with local anesthetic on length of hospital stay in subjects undergoing laparotomy.

* To evaluate the effects of preoperative TAP analgesia compared to surgeon-initiated wound infiltration with local anesthetic on postoperative anti-emetic use and number of recorded episodes of emesis in subjects undergoing laparotomy.

* To evaluate the effects of preoperative TAP analgesia compared to surgeon-initiated wound infiltration with local anesthetic on return of bowel function in subjects undergoing laparotomy.

* To evaluate the effects of preoperative TAP analgesia compared to surgeon-initiated wound infiltration with local anesthetic on subject satisfaction in subjects undergoing laparotomy.

* To evaluate the effects of preoperative TAP analgesia compared to surgeon-initiated wound infiltration with local anesthetic on postoperative complications in subjects undergoing laparotomy.

* To evaluate the effects of preoperative TAP analgesia compared to surgeon-initiated wound infiltration with local anesthetic on readmission rates in subjects undergoing laparotomy.

* To evaluate the cost of care associated with TAP analgesia compared to surgeon-initiated wound infiltration with local anesthetic on readmission rates in subjects undergoing laparotomy.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • Ability to understand and the willingness to sign a written informed consent document
  • Patients undergoing exploratory laparotomy via midline vertical skin incision for gynecologic indications at UW Hospital and Clinics
  • Patients must be >18 years old
  • English speaking (able to provide consent and complete questionnaires)
  • Patients must have the ability to understand visual and verbal pain scales
  • Patients must be eligible for TAP block placement. This will be confirmed during preoperative visit with the primary surgeon. Patient's are not eligible if they have allergies to the anesthetic medications or have had prior abdominal reconstructive surgery that would alter their abdominal wall anatomy in a way where the block would not be expected to be effective.
Exclusion Criteria
  • Known allergy to local anesthetics.
  • Known history of chronic pain disorders and/or chronic opioid use defined as greater than 10mg of PO morphine or equivalent used daily for at least 30 days prior to enrollment.
  • Patient has a history of opioid dependence requiring rehabilitation or the use of opioid antagonists.
  • Patients with a planned exploration with biopsies (no organs removed) will be excluded from the study.
  • Individuals who are pregnant, lactating or planning on becoming pregnant during the study.
  • Significant liver disease that would inhibit prescription of opioids.
  • Significant kidney disease that would inhibit administration of gabapentin.
  • Not suitable for study participation due to other reasons at the discretion of the investigators.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TAP Block plus LaparotomyTAP Anesthesia-
Laparotomy plus Local Wound AnestheticSurgeon-Initiated Local Anesthetic-
Primary Outcome Measures
NameTimeMethod
Total opioid use measured in oral morphine equivalents for the first 24 hours post-surgery24 hours post-surgery

Total opioid use measured in oral morphine equivalents for the first 24 hours post-surgery (including intraoperative and Post Anesthesia Care Unit (PACU) opioid utilization).

Secondary Outcome Measures
NameTimeMethod
Mean postoperative pain score for the first 24 hours post-surgery24 hours post-surgery

Mean postoperative pain score for the first 24 hours post-surgery, measured by the Numeric Rating Scale (NRS), which rates pain on a 0-10 scale (collected routinely on the post-operative floor). Higher numbers indicate worse pain.

Length of hospital stay, measured in whole hours from admission to PACU to time of discharge order placementestimated to be up to 3 days
Post-operative anti-emetic useestimated to be up to 3 days

A study team member will review the patient's medical chart to record the number of times an anti-emetic was given to the subject.

Number of recorded episodes of emesisestimated to be up to 3 days

A study team member will review the patient's medical chart to record number of times the hospital staff observed a participant vomit.

Return of bowel function measured in whole hours from completion of surgery to passage of flatusestimated to be up to 3 days
Participant Satisfaction at Postoperative Visit measured by two pain questions from the QoR-15 Patient Reported Outcomes Survey Scorepost-operative visit (up to 60 days)

Scores are from 0-10 where 0 is pain all of the time and 10 is pain none of the time.

Readmission rate measured by readmission in the 30 days following surgeryup to 30 days
Cost of care measured by aggregate cost of hospitalization following discharge from surgical hospital stayestimated to be up to 3 days
Summary of Post-operative Complicationsup to 30 days post-operatively

Postoperative complications, as defined by urinary tract infections, thromboembolic events, pneumonia, blood transfusion, cardiac events, falls, and electrolyte disturbances will be summarized by type and number of complications.

Time to First Ambulation measured in hoursestimated to be within 72 hours post-surgery

A study team member will review the participant's medical chart to record the interval (in hours) from completion of surgery to first ambulation after surgery.

Trial Locations

Locations (1)

University of Wisconsin Hospitals and Clinics (UWHC)

🇺🇸

Madison, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath